Ecto-ATPase CD39 Inactivates Isoprenoid-Derived Vγ9Vδ2 T Cell Phosphoantigens

Cell Reports

Volumn 16, Issue 2, 2016, Pages 444-456

  Gruenbacher, Georg ^a   Gander, Hubert ^a   Rahm, Andrea ^a   Idzko, Marco ^b   Nussbaumer, Oliver ^c   Thurnher, Martin ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF FREIBURG   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CD161 ANTIGEN; CD39 ANTIGEN; GERANYLGERANYL PYROPHOSPHATE; INTERLEUKIN 15; INTERLEUKIN 1BETA; ISOPRENOID; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; APYRASE; AUTOANTIGEN; ECTOATPASE; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; TERPENE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN HYDROLYSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; CELL CULTURE; ENZYME INDUCTION; ENZYMOLOGY; HYDROLYSIS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD; APYRASE; AUTOANTIGENS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; ENZYME INDUCTION; HUMANS; HYDROLYSIS; LYMPHOCYTE ACTIVATION; MICE, KNOCKOUT; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TERPENES;

EID: 84992521699     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.06.009     Document Type: Article

References (70)

1. Acosta-Rodriguez, E.V., Napolitani, G., Lanzavecchia, A., Sallusto, F., Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8 (2007), 942–949.
2. Airoldi, I., Bertaina, A., Prigione, I., Zorzoli, A., Pagliara, D., Cocco, C., Meazza, R., Loiacono, F., Lucarelli, B., Bernardo, M.E., et al. γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes. Blood 125 (2015), 2349–2358.
3. Antonioli, L., Pacher, P., Vizi, E.S., Haskó, G., CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 19 (2013), 355–367.
4. Bai, A., Moss, A., Rothweiler, S., Longhi, M.S., Wu, Y., Junger, W.G., Robson, S.C., NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine. Nat. Commun., 6, 2015, 8819.
5. Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., Roncarolo, M.G., Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177 (2006), 8338–8347.
6. Bonneville, M., O'Brien, R.L., Born, W.K., Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10 (2010), 467–478.
7. Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., Dell'Acqua, M.L., et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110 (2007), 1225–1232.
8. Brocks, J.J., Logan, G.A., Buick, R., Summons, R.E., Archean molecular fossils and the early rise of eukaryotes. Science 285 (1999), 1033–1036.
9. Burnstock, G., Boeynaems, J.M., Purinergic signalling and immune cells. Purinergic Signal. 10 (2014), 529–564.
10. Capra, V., Rovati, G.E., Mangano, P., Buccellati, C., Murphy, R.C., Sala, A., Transcellular biosynthesis of eicosanoid lipid mediators. Biochim. Biophys. Acta 1851 (2015), 377–382.
11. Chien, Y.H., Meyer, C., Bonneville, M., γδ T cells: first line of defense and beyond. Annu. Rev. Immunol. 32 (2014), 121–155.
12. Clendening, J.W., Pandyra, A., Boutros, P.C., El Ghamrasni, S., Khosravi, F., Trentin, G.A., Martirosyan, A., Hakem, A., Hakem, R., Jurisica, I., Penn, L.Z., Dysregulation of the mevalonate pathway promotes transformation. Proc. Natl. Acad. Sci. USA 107 (2010), 15051–15056.
13. Cohen, H.B., Briggs, K.T., Marino, J.P., Ravid, K., Robson, S.C., Mosser, D.M., TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses. Blood 122 (2013), 1935–1945.
14. Coscia, M., Vitale, C., Peola, S., Foglietta, M., Rigoni, M., Griggio, V., Castella, B., Angelini, D., Chiaretti, S., Riganti, C., et al. Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. Blood 120 (2012), 3271–3279.
15. Crick, D.C., Andres, D.A., Waechter, C.J., Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation. Biochem. Biophys. Res. Commun. 237 (1997), 483–487.
16. Dimova, T., Brouwer, M., Gosselin, F., Tassignon, J., Leo, O., Donner, C., Marchant, A., Vermijlen, D., Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc. Natl. Acad. Sci. USA 112 (2015), E556–E565.
17. Dombrowski, K.E., Ke, Y., Brewer, K.A., Kapp, J.A., Ecto-ATPase: an activation marker necessary for effector cell function. Immunol. Rev. 161 (1998), 111–118.
18. Dunn, S.E., Youssef, S., Goldstein, M.J., Prod'homme, T., Weber, M.S., Zamvil, S.S., Steinman, L., Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J. Exp. Med. 203 (2006), 401–412.
19. Dwyer, K.M., Deaglio, S., Gao, W., Friedman, D., Strom, T.B., Robson, S.C., CD39 and control of cellular immune responses. Purinergic Signal. 3 (2007), 171–180.
20. Eltzschig, H.K., Sitkovsky, M.V., Robson, S.C., Purinergic signaling during inflammation. N. Engl. J. Med. 367 (2012), 2322–2333.
21. Enjyoji, K., Sévigny, J., Lin, Y., Frenette, P.S., Christie, P.D., Esch, J.S. 2nd, Imai, M., Edelberg, J.M., Rayburn, H., Lech, M., et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat. Med. 5 (1999), 1010–1017.
22. Fang, F., Yu, M., Cavanagh, M.M., Hutter Saunders, J., Qi, Q., Ye, Z., Le Saux, S., Sultan, W., Turgano, E., Dekker, C.L., et al. Expression of CD39 on activated T cells impairs their survival in older individuals. Cell Rep. 14 (2016), 1218–1231.
23. Fergusson, J.R., Smith, K.E., Fleming, V.M., Rajoriya, N., Newell, E.W., Simmons, R., Marchi, E., Björkander, S., Kang, Y.H., Swadling, L., et al. CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep. 9 (2014), 1075–1088.
24. Frascoli, M., Marcandalli, J., Schenk, U., Grassi, F., Purinergic P2X7 receptor drives T cell lineage choice and shapes peripheral γδ cells. J. Immunol. 189 (2012), 174–180.
25. Freed-Pastor, W.A., Mizuno, H., Zhao, X., Langerød, A., Moon, S.H., Rodriguez-Barrueco, R., Barsotti, A., Chicas, A., Li, W., Polotskaia, A., et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 148 (2012), 244–258.
26. Gentles, A.J., Newman, A.M., Liu, C.L., Bratman, S.V., Feng, W., Kim, D., Nair, V.S., Xu, Y., Khuong, A., Hoang, C.D., et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21 (2015), 938–945.
27. Gober, H.J., Kistowska, M., Angman, L., Jenö, P., Mori, L., De Libero, G., Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197 (2003), 163–168.
28. Godder, K.T., Henslee-Downey, P.J., Mehta, J., Park, B.S., Chiang, K.Y., Abhyankar, S., Lamb, L.S., Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant. 39 (2007), 751–757.
29. Godfrey, D.I., Uldrich, A.P., McCluskey, J., Rossjohn, J., Moody, D.B., The burgeoning family of unconventional T cells. Nat. Immunol. 16 (2015), 1114–1123.
30. Grinthal, A., Guidotti, G., CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why?. Purinergic Signal. 2 (2006), 391–398.
31. Gruenbacher, G., Nussbaumer, O., Gander, H., Steiner, B., Leonhartsberger, N., Thurnher, M., Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism. OncoImmunology, 3, 2014, e953410.
32. Harly, C., Guillaume, Y., Nedellec, S., Peigné, C.M., Mönkkönen, H., Mönkkönen, J., Li, J., Kuball, J., Adams, E.J., Netzer, S., et al. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. Blood 120 (2012), 2269–2279.
33. Harris, K.M., Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Th1 responses that are contact-dependent and mediated by IL-15. J. Leukoc. Biol. 90 (2011), 727–734.
34. Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Willart, M.A., Muskens, F., Hoogsteden, H.C., Luttmann, W., Ferrari, D., Di Virgilio, F., et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13 (2007), 913–919.
35. Idzko, M., Ferrari, D., Eltzschig, H.K., Nucleotide signalling during inflammation. Nature 509 (2014), 310–317.
36. Jabri, B., Abadie, V., IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction. Nat. Rev. Immunol. 15 (2015), 771–783.
37. Kabelitz, D., He, W., The multifunctionality of human Vγ9Vδ2 γδ T cells: clonal plasticity or distinct subsets?. Scand. J. Immunol. 76 (2012), 213–222.
38. Kabelitz, D., Kalyan, S., Oberg, H.H., Wesch, D., Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity. OncoImmunology, 2, 2013, e23304.
39. Karunakaran, M.M., Göbel, T.W., Starick, L., Walter, L., Herrmann, T., Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos). Immunogenetics 66 (2014), 243–254.
40. Kasinrerk, W., Baumruker, T., Majdic, O., Knapp, W., Stockinger, H., CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. J. Immunol. 150 (1993), 579–584.
41. Khakh, B.S., Molecular physiology of P2X receptors and ATP signalling at synapses. Nat. Rev. Neurosci. 2 (2001), 165–174.
42. Komoszyński, M., Wojtczak, A., Apyrases (ATP diphosphohydrolases, EC 3.6.1.5): function and relationship to ATPases. Biochim. Biophys. Acta 1310 (1996), 233–241.
43. Krutzik, S.R., Tan, B., Li, H., Ochoa, M.T., Liu, P.T., Sharfstein, S.E., Graeber, T.G., Sieling, P.A., Liu, Y.J., Rea, T.H., et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11 (2005), 653–660.
44. Lalor, S.J., Dungan, L.S., Sutton, C.E., Basdeo, S.A., Fletcher, J.M., Mills, K.H., Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J. Immunol. 186 (2011), 5738–5748.
45. Liang, D., Zuo, A., Shao, H., Chen, M., Kaplan, H.J., Sun, D., Roles of the adenosine receptor and CD73 in the regulatory effect of γδ T cells. PLoS ONE, 9, 2014, e108932.
46. Matsushima, K., Larsen, C.G., DuBois, G.C., Oppenheim, J.J., Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169 (1989), 1485–1490.
47. Mizumoto, N., Kumamoto, T., Robson, S.C., Sévigny, J., Matsue, H., Enjyoji, K., Takashima, A., CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat. Med. 8 (2002), 358–365.
48. Mohamadzadeh, M., Berard, F., Essert, G., Chalouni, C., Pulendran, B., Davoust, J., Bridges, G., Palucka, A.K., Banchereau, J., Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med. 194 (2001), 1013–1020.
49. Mookerjee-Basu, J., Vantourout, P., Martinez, L.O., Perret, B., Collet, X., Périgaud, C., Peyrottes, S., Champagne, E., F1-adenosine triphosphatase displays properties characteristic of an antigen presentation molecule for Vgamma9Vdelta2 T cells. J. Immunol. 184 (2010), 6920–6928.
50. Peters, W., Scott, H.M., Chambers, H.F., Flynn, J.L., Charo, I.F., Ernst, J.D., Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 98 (2001), 7958–7963.
51. Piccini, A., Carta, S., Tassi, S., Lasiglié, D., Fossati, G., Rubartelli, A., ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc. Natl. Acad. Sci. USA 105 (2008), 8067–8072.
52. Rachmilewitz, J., Lanzavecchia, A., A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding. Trends Immunol. 23 (2002), 592–595.
53. Ribot, J.C., Ribeiro, S.T., Correia, D.V., Sousa, A.E., Silva-Santos, B., Human γδ thymocytes are functionally immature and differentiate into cytotoxic type 1 effector T cells upon IL-2/IL-15 signaling. J. Immunol. 192 (2014), 2237–2243.
54. Robson, S.C., Wu, Y., Sun, X., Knosalla, C., Dwyer, K., Enjyoji, K., Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin. Thromb. Hemost. 31 (2005), 217–233.
55. Sakaki, H., Tsukimoto, M., Harada, H., Moriyama, Y., Kojima, S., Autocrine regulation of macrophage activation via exocytosis of ATP and activation of P2Y11 receptor. PLoS ONE, 8, 2013, e59778.
56. Sandstrom, A., Peigné, C.M., Léger, A., Crooks, J.E., Konczak, F., Gesnel, M.C., Breathnach, R., Bonneville, M., Scotet, E., Adams, E.J., The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. Immunity 40 (2014), 490–500.
57. Scotet, E., Martinez, L.O., Grant, E., Barbaras, R., Jenö, P., Guiraud, M., Monsarrat, B., Saulquin, X., Maillet, S., Estève, J.P., et al. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 22 (2005), 71–80.
58. Shen, Y., Zhou, D., Qiu, L., Lai, X., Simon, M., Shen, L., Kou, Z., Wang, Q., Jiang, L., Estep, J., et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 295 (2002), 2255–2258.
59. Silva-Santos, B., Serre, K., Norell, H., γδ T cells in cancer. Nat. Rev. Immunol. 15 (2015), 683–691.
60. Szatmari, I., Gogolak, P., Im, J.S., Dezso, B., Rajnavolgyi, E., Nagy, L., Activation of PPARgamma specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. Immunity 21 (2004), 95–106.
61. Tanaka, Y., Morita, C.T., Tanaka, Y., Nieves, E., Brenner, M.B., Bloom, B.R., Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375 (1995), 155–158.
62. Tel, J., Anguille, S., Waterborg, C.E., Smits, E.L., Figdor, C.G., de Vries, I.J., Tumoricidal activity of human dendritic cells. Trends Immunol. 35 (2014), 38–46.
63. Thurnher, M., Gruenbacher, G., T lymphocyte regulation by mevalonate metabolism. Sci. Signal., 8, 2015, re4.
64. Thurnher, M., Nussbaumer, O., Gruenbacher, G., Novel aspects of mevalonate pathway inhibitors as antitumor agents. Clin. Cancer Res. 18 (2012), 3524–3531.
65. Van Seventer, G.A., Shimizu, Y., Horgan, K.J., Shaw, S., The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144 (1990), 4579–4586.
66. Vantourout, P., Hayday, A., Six-of-the-best: unique contributions of γδ T cells to immunology. Nat. Rev. Immunol. 13 (2013), 88–100.
67. Vavassori, S., Kumar, A., Wan, G.S., Ramanjaneyulu, G.S., Cavallari, M., El Daker, S., Beddoe, T., Theodossis, A., Williams, N.K., Gostick, E., et al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells. Nat. Immunol. 14 (2013), 908–916.
68. Wang, H., Sarikonda, G., Puan, K.J., Tanaka, Y., Feng, J., Giner, J.L., Cao, R., Mönkkönen, J., Oldfield, E., Morita, C.T., Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism. J. Immunol. 187 (2011), 5099–5113.
69. Weivoda, M.M., Hohl, R.J., Geranylgeranyl pyrophosphate stimulates PPARγ expression and adipogenesis through the inhibition of osteoblast differentiation. Bone 50 (2012), 467–476.
70. Wilhelm, M., Smetak, M., Schaefer-Eckart, K., Kimmel, B., Birkmann, J., Einsele, H., Kunzmann, V., Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells. J. Transl. Med., 12, 2014, 45.